We are live on ! Find out more
ANIK icon

Anika Therapeutics

159 hedge funds and large institutions have $505M invested in Anika Therapeutics in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 68 increasing their positions, 49 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more call options, than puts

Call options by funds: $2.42M | Put options by funds: $1.28M

39% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 49

5% more capital invested

Capital invested by funds: $483M → $505M (+$22.1M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

1% less funds holding

Funds holding: 160159 (-1)

Holders
159
Holders Change
-1
Holders Change %
-0.63%
% of All Funds
4.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
68
Reduced
49
Closed
15
Calls
$2.42M
Puts
$1.28M
Net Calls
+$1.14M
Net Calls Change
+$2.7M
Name Holding Trade Value Shares
Change
Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$36.7M +$2.46M +60,739 +7%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$35.5M +$858K +21,212 +3%
LCP
3
Lombardia Capital Partners
California
$30.4M +$24.2M +598,662 +426%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$29.3M -$3.71M -91,843 -11%
BTW
5
Boston Trust Walden
Massachusetts
$28.8M -$582K -14,385 -2%
TSW
6
Thompson Siegel & Walmsley
Virginia
$27.9M +$862K +21,328 +3%
Vanguard Group
7
Vanguard Group
Pennsylvania
$27.3M +$380K +9,391 +1%
BIT
8
BlackRock Institutional Trust
California
$21.9M -$517K -12,799 -2%
RIM
9
Ranger Investment Management
Texas
$17M +$51.7K +1,280 +0.3%
PCM
10
Portolan Capital Management
Massachusetts
$15M +$2.28M +56,332 +18%
State Street
11
State Street
Massachusetts
$12.9M +$736K +18,200 +6%
AAM
12
AMI Asset Management
California
$12.6M +$1.37M +33,980 +12%
Allianz Asset Management
13
Allianz Asset Management
Germany
$11.8M -$3.48M -85,963 -23%
GAM
14
Gotham Asset Management
New York
$11.5M -$2.77M -68,609 -20%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$11M +$907K +22,429 +9%
AQR Capital Management
16
AQR Capital Management
Connecticut
$8.31M -$902K -22,301 -10%
Northern Trust
17
Northern Trust
Illinois
$7.42M +$32.7K +809 +0.5%
TAM
18
THB Asset Management
Connecticut
$7.37M +$5.41M +133,743 +295%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$7.33M +$4.5M +111,429 +167%
BA
20
BlackRock Advisors
Delaware
$7.11M +$56K +1,385 +0.8%
Charles Schwab
21
Charles Schwab
California
$6.14M
TA
22
Teachers Advisors
New York
$5.65M +$522K +12,900 +10%
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$4.91M +$3.22M +79,763 +202%
Renaissance Technologies
24
Renaissance Technologies
New York
$4.63M -$4.05M -100,300 -47%
American Century Companies
25
American Century Companies
Missouri
$4.29M -$32.7K -809 -0.8%

ANIK Hedge Fund Activity: Q1 2015 in Review

159 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2015, worth a combined $505M — up 4.6% from $483M a quarter earlier.

Fund positioning in ANIK was balanced in Q1 2015: 15 funds opened new positions, 15 closed out, 68 added to existing stakes and 49 trimmed.

The largest buyer was Lombardia Capital Partners, adding an estimated $24.2M. The largest seller was Millennium Management, cutting an estimated $4.86M.

  • 159 institutional investors held Anika Therapeutics (ANIK) as of Q1 2015, down from 160 in Q4 2014.
  • Funds reported $505M of Anika Therapeutics stock for Q1 2015, up 4.6% quarter-over-quarter.
  • 15 funds opened new Anika Therapeutics positions in Q1 2015 and 15 closed out, a net change of 0 holders.
  • The largest Anika Therapeutics buyer in Q1 2015 was Lombardia Capital Partners, an estimated $24.2M added.
  • The largest Anika Therapeutics seller in Q1 2015 was Millennium Management, an estimated $4.86M sold.

Based on aggregated 13F filings for Q1 2015.